Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 201 entries
Sorted by: Best Match Show Resources per page
Attracting prospective STEM teachers using realistic job previews: A mixed methods study

STEM training programs

Bardach L, Klassen RM.
GSID: 7v95c2crsC0J
RM Klassen, H Granger, L Bardach - European Journal of Teacher …, 2022 - Taylor & Francis

… The participants were enrolled in the following degree programmes: … in cross-degree programmes with a STEM component. … , where applicants to teacher training have been, until the …

Cite
Klassen, R. M., Granger, H., & Bardach, L. (2022). Attracting prospective STEM teachers using realistic job previews: A mixed methods study. European Journal of Teacher Education, 1-23.
Klassen, Robert M., Helen Granger, and Lisa Bardach. "Attracting prospective STEM teachers using realistic job previews: A mixed methods study." European Journal of Teacher Education (2022): 1-23.
Copy Download .nbib Format: MLA
Safety of COVID-19 vaccines, their components or their platforms for pregnant women: A rapid review

Non-school settings

Bardach A, Ciapponi A.
GSID: 8Ui7LWVEFQ4J
A Ciapponi, A Bardach, A Mazzoni, T Alconada… - medRxiv, 2021 - ncbi.nlm.nih.gov

Background Pregnant women with COVID-19 are at an increased risk of severe COVID-19 illness as well as adverse pregnancy and birth outcomes. Many countries are vaccinating or …

Cite
Ciapponi, A., Bardach, A., Mazzoni, A., Alconada, T., Anderson, S., Argento, F. J., ... & Buekens, P. M. (2021). Safety of COVID-19 vaccines, their components or their platforms for pregnant women: A rapid review. medRxiv.
Ciapponi, Agustín, et al. "Safety of COVID-19 vaccines, their components or their platforms for pregnant women: A rapid review." medRxiv (2021).
Copy Download .nbib Format: MLA
Role of Dose Intensification for Salvage Radiation Therapy after Radical Prostatectomy.

Frontiers in oncology

Beck M, Barelkowski T, Kaul D, Wecker S, Thieme AH, Zwahlen DR, Wust P, Aebersold DM, Budach V, Ghadjar P.
PMID: 26973815
Front Oncol. 2016 Mar 01;6:48. doi: 10.3389/fonc.2016.00048. eCollection 2016.

For primary radiation therapy (RT) of prostate cancer, dose intensification is established as standard of care. Less is known on the role of dose intensification in the postprostatectomy setting for salvage RT. Thus, we aimed to identify and summarize...

Cite
Beck M, Barelkowski T, Kaul D, et al. Role of Dose Intensification for Salvage Radiation Therapy after Radical Prostatectomy. Front Oncol. 2016;6:48doi: 10.3389/fonc.2016.00048.
Beck, M., Barelkowski, T., Kaul, D., Wecker, S., Thieme, A. H., Zwahlen, D. R., Wust, P., Aebersold, D. M., Budach, V., & Ghadjar, P. (2016). Role of Dose Intensification for Salvage Radiation Therapy after Radical Prostatectomy. Frontiers in oncology, 648. https://doi.org/10.3389/fonc.2016.00048
Beck, Marcus, et al. "Role of Dose Intensification for Salvage Radiation Therapy after Radical Prostatectomy." Frontiers in oncology vol. 6 (2016): 48. doi: https://doi.org/10.3389/fonc.2016.00048
Beck M, Barelkowski T, Kaul D, Wecker S, Thieme AH, Zwahlen DR, Wust P, Aebersold DM, Budach V, Ghadjar P. Role of Dose Intensification for Salvage Radiation Therapy after Radical Prostatectomy. Front Oncol. 2016 Mar 01;6:48. doi: 10.3389/fonc.2016.00048. eCollection 2016. PMID: 26973815; PMCID: PMC4771737.
Copy Download .nbib Format: NLM
The Problem with Big Data: Operating on Smaller Datasets to Bridge the Implementation Gap.

Frontiers in public health

Mann RP, Mushtaq F, White AD, Mata-Cervantes G, Pike T, Coker D, Murdoch S, Hiles T, Smith C, Berridge D, Hinchliffe S, Hall G, Smye S, Wilkie RM, Lodge JP, Mon-Williams M.
PMID: 27990415
Front Public Health. 2016 Dec 01;4:248. doi: 10.3389/fpubh.2016.00248. eCollection 2016.

Big datasets have the potential to revolutionize public health. However, there is a mismatch between the political and scientific optimism surrounding big data and the public's perception of its benefit. We suggest a systematic and concerted emphasis on developing...

Cite
Mann RP, Mushtaq F, White AD, et al. The Problem with Big Data: Operating on Smaller Datasets to Bridge the Implementation Gap. Front Public Health. 2016;4:248doi: 10.3389/fpubh.2016.00248.
Mann, R. P., Mushtaq, F., White, A. D., Mata-Cervantes, G., Pike, T., Coker, D., Murdoch, S., Hiles, T., Smith, C., Berridge, D., Hinchliffe, S., Hall, G., Smye, S., Wilkie, R. M., Lodge, J. P., & Mon-Williams, M. (2016). The Problem with Big Data: Operating on Smaller Datasets to Bridge the Implementation Gap. Frontiers in public health, 4248. https://doi.org/10.3389/fpubh.2016.00248
Mann, Richard P, et al. "The Problem with Big Data: Operating on Smaller Datasets to Bridge the Implementation Gap." Frontiers in public health vol. 4 (2016): 248. doi: https://doi.org/10.3389/fpubh.2016.00248
Mann RP, Mushtaq F, White AD, Mata-Cervantes G, Pike T, Coker D, Murdoch S, Hiles T, Smith C, Berridge D, Hinchliffe S, Hall G, Smye S, Wilkie RM, Lodge JP, Mon-Williams M. The Problem with Big Data: Operating on Smaller Datasets to Bridge the Implementation Gap. Front Public Health. 2016 Dec 01;4:248. doi: 10.3389/fpubh.2016.00248. eCollection 2016. PMID: 27990415; PMCID: PMC5130981.
Copy Download .nbib Format: NLM
NEW ASPECTS REGARDING NEOADJUVANT RADIOCHEMOTHERAPY IN LOCALLY ADVANCED NONINFLAMMATORY BREAST CANCER AND PREDICTIVE FACTORS FOR A PATHOLOGIC COMPLETE REMISSION: IGCS-0016 Breast Cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Matuschek C, Boelke E, Budach W, Speer V, Bojar H, Audretsch W, Nestle K.
PMID: 25955892
Int J Gynecol Cancer. 2015 May;25:1. doi: 10.1097/00009577-201505001-00001.

No abstract available.

Cite
Matuschek C, Boelke E, Budach W, et al. NEW ASPECTS REGARDING NEOADJUVANT RADIOCHEMOTHERAPY IN LOCALLY ADVANCED NONINFLAMMATORY BREAST CANCER AND PREDICTIVE FACTORS FOR A PATHOLOGIC COMPLETE REMISSION: IGCS-0016 Breast Cancer. Int J Gynecol Cancer. 2015;25:1doi: 10.1097/00009577-201505001-00001.
Matuschek, C., Boelke, E., Budach, W., Speer, V., Bojar, H., Audretsch, W., & Nestle, K. (2015). NEW ASPECTS REGARDING NEOADJUVANT RADIOCHEMOTHERAPY IN LOCALLY ADVANCED NONINFLAMMATORY BREAST CANCER AND PREDICTIVE FACTORS FOR A PATHOLOGIC COMPLETE REMISSION: IGCS-0016 Breast Cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 251. https://doi.org/10.1097/00009577-201505001-00001
Matuschek, C, et al. "NEW ASPECTS REGARDING NEOADJUVANT RADIOCHEMOTHERAPY IN LOCALLY ADVANCED NONINFLAMMATORY BREAST CANCER AND PREDICTIVE FACTORS FOR A PATHOLOGIC COMPLETE REMISSION: IGCS-0016 Breast Cancer." International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 25 (2015): 1. doi: https://doi.org/10.1097/00009577-201505001-00001
Matuschek C, Boelke E, Budach W, Speer V, Bojar H, Audretsch W, Nestle K. NEW ASPECTS REGARDING NEOADJUVANT RADIOCHEMOTHERAPY IN LOCALLY ADVANCED NONINFLAMMATORY BREAST CANCER AND PREDICTIVE FACTORS FOR A PATHOLOGIC COMPLETE REMISSION: IGCS-0016 Breast Cancer. Int J Gynecol Cancer. 2015 May;25:1. doi: 10.1097/00009577-201505001-00001. PMID: 25955892.
Copy Download .nbib Format: NLM
Hypofractionated Radiotherapy as Adjuvant Treatment in Early Breast Cancer. A Review and Meta-Analysis of Randomized Controlled Trials.

Breast care (Basel, Switzerland)

Budach W, Bölke E, Matuschek C.
PMID: 26600759
Breast Care (Basel). 2015 Aug;10(4):240-5. doi: 10.1159/000439007. Epub 2015 Aug 19.

BACKGROUND: Adjuvant radiotherapy after breast-conserving surgery is indicated in the vast majority of breast cancer patients. Conventionally fractionated radiotherapy with 50 Gy in 25 fractions was considered standard of care for several decades. The recently publishes long-term results of...

Cite
Budach W, Bölke E, Matuschek C. Hypofractionated Radiotherapy as Adjuvant Treatment in Early Breast Cancer. A Review and Meta-Analysis of Randomized Controlled Trials. Breast Care (Basel). 2015;10(4):240-5doi: 10.1159/000439007.
Budach, W., Bölke, E., & Matuschek, C. (2015). Hypofractionated Radiotherapy as Adjuvant Treatment in Early Breast Cancer. A Review and Meta-Analysis of Randomized Controlled Trials. Breast care (Basel, Switzerland), 10(4), 240-5. https://doi.org/10.1159/000439007
Budach, Wilfried, et al. "Hypofractionated Radiotherapy as Adjuvant Treatment in Early Breast Cancer. A Review and Meta-Analysis of Randomized Controlled Trials." Breast care (Basel, Switzerland) vol. 10,4 (2015): 240-5. doi: https://doi.org/10.1159/000439007
Budach W, Bölke E, Matuschek C. Hypofractionated Radiotherapy as Adjuvant Treatment in Early Breast Cancer. A Review and Meta-Analysis of Randomized Controlled Trials. Breast Care (Basel). 2015 Aug;10(4):240-5. doi: 10.1159/000439007. Epub 2015 Aug 19. PMID: 26600759; PMCID: PMC4608603.
Copy Download .nbib Format: NLM
[Not Available].

Gastroenterologie clinique et biologique

Pilleul F, Buc E, Dupas JL, Boyer J, Bruel JM, Berdah S.
PMID: 24928749
Gastroenterol Clin Biol. 2007 Sep;31(8):47-52. doi: 10.1016/S0399-8320(07)91951-X. Epub 2007 Oct 30.

No abstract available.

Cite
Pilleul F, Buc E, Dupas JL, et al. Prise en charge de l'hémorragie d'origine diverticulaire. [Not Available]. Gastroenterol Clin Biol. 2007;31(8):47-52doi: 10.1016/S0399-8320(07)91951-X.
Pilleul, F., Buc, E., Dupas, J. L., Boyer, J., Bruel, J. M., & Berdah, S. (2007). Prise en charge de l'hémorragie d'origine diverticulaire. [Not Available]. Gastroenterologie clinique et biologique, 31(8), 47-52. https://doi.org/10.1016/S0399-8320(07)91951-X
Pilleul, Franck, et al. "Prise en charge de l'hémorragie d'origine diverticulaire." [Not Available]. Gastroenterologie clinique et biologique vol. 31,8 (2007): 47-52. doi: https://doi.org/10.1016/S0399-8320(07)91951-X
Pilleul F, Buc E, Dupas JL, Boyer J, Bruel JM, Berdah S. Prise en charge de l'hémorragie d'origine diverticulaire. [Not Available]. Gastroenterol Clin Biol. 2007 Sep;31(8):47-52. doi: 10.1016/S0399-8320(07)91951-X. Epub 2007 Oct 30. French. PMID: 24928749.
Copy Download .nbib Format: NLM
Dendrimers with Oligospiroketal (OSK) Building Blocks: Synthesis and Properties.

Chemistry (Weinheim an der Bergstrasse, Germany)

Wessig P, Budach D, Thünemann AF.
PMID: 26094735
Chemistry. 2015 Jul 13;21(29):10466-71. doi: 10.1002/chem.201501386. Epub 2015 Jun 11.

The development of novel dendrimers containing oligospiroketal (OSK) rods as building blocks is described. The linkage between the core unit (CU), branching units (BU), and OSK rods relies on the CuAAC reaction between terminal alkynes and azides. Two different...

Cite
Wessig P, Budach D, Thünemann AF. Dendrimers with Oligospiroketal (OSK) Building Blocks: Synthesis and Properties. Chemistry. 2015;21(29):10466-71doi: 10.1002/chem.201501386.
Wessig, P., Budach, D., & Thünemann, A. F. (2015). Dendrimers with Oligospiroketal (OSK) Building Blocks: Synthesis and Properties. Chemistry (Weinheim an der Bergstrasse, Germany), 21(29), 10466-71. https://doi.org/10.1002/chem.201501386
Wessig, Pablo, et al. "Dendrimers with Oligospiroketal (OSK) Building Blocks: Synthesis and Properties." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 21,29 (2015): 10466-71. doi: https://doi.org/10.1002/chem.201501386
Wessig P, Budach D, Thünemann AF. Dendrimers with Oligospiroketal (OSK) Building Blocks: Synthesis and Properties. Chemistry. 2015 Jul 13;21(29):10466-71. doi: 10.1002/chem.201501386. Epub 2015 Jun 11. PMID: 26094735.
Copy Download .nbib Format: NLM
The membrane targeted apoptosis modulators erucylphosphocholine and erucylphosphohomocholine increase the radiation response of human glioblastoma cell lines in vitro.

Radiation oncology (London, England)

Rübel A, Handrick R, Lindner LH, Steiger M, Eibl H, Budach W, Belka C, Jendrossek V.
PMID: 16722524
Radiat Oncol. 2006 Mar 29;1:6. doi: 10.1186/1748-717X-1-6.

BACKGROUND: Alkylphosphocholines constitute a novel class of antineoplastic synthetic phospholipid derivatives that induce apoptosis of human tumor cell lines by targeting cellular membranes. We could recently show that the first intravenously applicable alkylphosphocholine erucylphosphocholine (ErPC) is a potent inducer...

Cite
Rübel A, Handrick R, Lindner LH, et al. The membrane targeted apoptosis modulators erucylphosphocholine and erucylphosphohomocholine increase the radiation response of human glioblastoma cell lines in vitro. Radiat Oncol. 2006;1:6doi: 10.1186/1748-717X-1-6.
Rübel, A., Handrick, R., Lindner, L. H., Steiger, M., Eibl, H., Budach, W., Belka, C., & Jendrossek, V. (2006). The membrane targeted apoptosis modulators erucylphosphocholine and erucylphosphohomocholine increase the radiation response of human glioblastoma cell lines in vitro. Radiation oncology (London, England), 16. https://doi.org/10.1186/1748-717X-1-6
Rübel, Amelie, et al. "The membrane targeted apoptosis modulators erucylphosphocholine and erucylphosphohomocholine increase the radiation response of human glioblastoma cell lines in vitro." Radiation oncology (London, England) vol. 1 (2006): 6. doi: https://doi.org/10.1186/1748-717X-1-6
Rübel A, Handrick R, Lindner LH, Steiger M, Eibl H, Budach W, Belka C, Jendrossek V. The membrane targeted apoptosis modulators erucylphosphocholine and erucylphosphohomocholine increase the radiation response of human glioblastoma cell lines in vitro. Radiat Oncol. 2006 Mar 29;1:6. doi: 10.1186/1748-717X-1-6. PMID: 16722524; PMCID: PMC1475859.
Copy Download .nbib Format: NLM
Therapeutic anticoagulant does not modify thromboses rate vein after venous reconstruction following pancreaticoduodenectomy.

Gastroenterology research and practice

Ouaïssi M, Sielezneff I, Pirro N, Bon Mardion R, Chaix JB, Merad A, Berdah S, Moutardier V, Cresti S, Emungania O, Anderson L, Christian B, Bernard S.
PMID: 19043605
Gastroenterol Res Pract. 2008;2008:896320. doi: 10.1155/2008/896320. Epub 2008 Nov 23.

Recommendations for anticoagulation following major venous reconstruction for pancreatic adenocarcinoma (PA) are not clearly established. The aim of our study was to find out the relation between postoperative anticoagulant treatment and thrombosis rate after portal venous resection. Materials and...

Cite
Ouaïssi M, Sielezneff I, Pirro N, et al. Therapeutic anticoagulant does not modify thromboses rate vein after venous reconstruction following pancreaticoduodenectomy. Gastroenterol Res Pract. 2008;2008:896320doi: 10.1155/2008/896320.
Ouaïssi, M., Sielezneff, I., Pirro, N., Bon Mardion, R., Chaix, J. B., Merad, A., Berdah, S., Moutardier, V., Cresti, S., Emungania, O., Anderson, L., Christian, B., & Bernard, S. (2008). Therapeutic anticoagulant does not modify thromboses rate vein after venous reconstruction following pancreaticoduodenectomy. Gastroenterology research and practice, 2008896320. https://doi.org/10.1155/2008/896320
Ouaïssi, Mehdi, et al. "Therapeutic anticoagulant does not modify thromboses rate vein after venous reconstruction following pancreaticoduodenectomy." Gastroenterology research and practice vol. 2008 (2008): 896320. doi: https://doi.org/10.1155/2008/896320
Ouaïssi M, Sielezneff I, Pirro N, Bon Mardion R, Chaix JB, Merad A, Berdah S, Moutardier V, Cresti S, Emungania O, Anderson L, Christian B, Bernard S. Therapeutic anticoagulant does not modify thromboses rate vein after venous reconstruction following pancreaticoduodenectomy. Gastroenterol Res Pract. 2008;2008:896320. doi: 10.1155/2008/896320. Epub 2008 Nov 23. PMID: 19043605; PMCID: PMC2586661.
Copy Download .nbib Format: NLM
Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases.

International archives of medicine

Wernicke CM, Grunewald TG, Hendrik J, Kuci S, Kuci Z, Koehl U, Mueller I, Doering M, Peters C, Lawitschka A, Kolb HJ, Bader P, Burdach S, von Luettichau I.
PMID: 21843360
Int Arch Med. 2011 Aug 15;4(1):27. doi: 10.1186/1755-7682-4-27.

Severe acute graft versus host disease (GvHD) is a life-threatening complication after allogeneic hematopoietic stem cell transplantation. Human mesenchymal stromal cells (MSCs) play an important role in endogenous tissue repair and possess strong immune-modulatory properties making them a promising...

Cite
Wernicke CM, Grunewald TG, Hendrik J, et al. Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases. Int Arch Med. 2011;4(1):27doi: 10.1186/1755-7682-4-27.
Wernicke, C. M., Grunewald, T. G., Hendrik, J., Kuci, S., Kuci, Z., Koehl, U., Mueller, I., Doering, M., Peters, C., Lawitschka, A., Kolb, H. J., Bader, P., Burdach, S., & von Luettichau, I. (2011). Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases. International archives of medicine, 4(1), 27. https://doi.org/10.1186/1755-7682-4-27
Wernicke, Caroline M, et al. "Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases." International archives of medicine vol. 4,1 (2011): 27. doi: https://doi.org/10.1186/1755-7682-4-27
Wernicke CM, Grunewald TG, Hendrik J, Kuci S, Kuci Z, Koehl U, Mueller I, Doering M, Peters C, Lawitschka A, Kolb HJ, Bader P, Burdach S, von Luettichau I. Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases. Int Arch Med. 2011 Aug 15;4(1):27. doi: 10.1186/1755-7682-4-27. PMID: 21843360; PMCID: PMC3169455.
Copy Download .nbib Format: NLM
1 W of stable single-frequency output at 1.03 mum from a novel, monolithic, non-planar Yb:YAG ring laser operating at room temperature.

Optics express

Burdack P, Fox T, Bode M, Freitag I.
PMID: 19516588
Opt Express. 2006 May 15;14(10):4363-7. doi: 10.1364/oe.14.004363.

We demonstrate, for the first time to our knowledge, a longitudinally diode-pumped, monolithic ytterbium ion-doped YAG non-planar ring laser (NPRO). We achieved a continuous-wave (cw) single-frequency output power of 1 W with 45.0% slope efficiency and a beam quality...

Cite
Burdack P, Fox T, Bode M, et al. 1 W of stable single-frequency output at 1.03 mum from a novel, monolithic, non-planar Yb:YAG ring laser operating at room temperature. Opt Express. 2006;14(10):4363-7doi: 10.1364/oe.14.004363.
Burdack, P., Fox, T., Bode, M., & Freitag, I. (2006). 1 W of stable single-frequency output at 1.03 mum from a novel, monolithic, non-planar Yb:YAG ring laser operating at room temperature. Optics express, 14(10), 4363-7. https://doi.org/10.1364/oe.14.004363
Burdack, Peer, et al. "1 W of stable single-frequency output at 1.03 mum from a novel, monolithic, non-planar Yb:YAG ring laser operating at room temperature." Optics express vol. 14,10 (2006): 4363-7. doi: https://doi.org/10.1364/oe.14.004363
Burdack P, Fox T, Bode M, Freitag I. 1 W of stable single-frequency output at 1.03 mum from a novel, monolithic, non-planar Yb:YAG ring laser operating at room temperature. Opt Express. 2006 May 15;14(10):4363-7. doi: 10.1364/oe.14.004363. PMID: 19516588.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 201 entries